METHOD FOR PREDICTING THE OUTCOME OF VIRAL PNEUMONIA IN COVID-19 Russian patent published in 2022 - IPC A61B5/08 A61B5/145 A61B5/1455 A61B6/02 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to clinical, laboratory and radiation diagnostics. In order to predict the outcome of viral pneumonia in COVID-19, the total volume of pulmonary involvement, pulmonary ventilation status, lactate dehydrogenase level, respiratory rate, oxygenation level are evaluated starting from 7th day of hospitalization. Total volume of pulmonary involvement "up to 25.5 %" is estimated at 13 points, from "25.5 to 50.5 %, including 25.5 %" — 14 points, "from 50.5 to 75.5 %, including 50.5 %" — 16 points, "75.5 % and more" — 17 points; no ventilation — 1 point, oxygen therapy — 2 points, non-invasive artificial pulmonary ventilation — 3 points, artificial pulmonary ventilation — 4 points; level of lactate dehydrogenase "up to 344.5 units/l" — 2 points, "344.5 to 445.5 units/l, including 344.5 units/l" — 3 points, "445.5 units/l and more" — 5 points; respiratory rate "up to 21.5 per minute" — 2 points, "21.5 and more per minute" — 8 points, oxygenation level "SPO2 93.5 and more" — 3 points, "SPO2 less 93.5" — 7 points. Obtained points are summed up. If the total score is 31 and less, a favorable outcome is predicted, while the total score is 32 and more — an unfavorable outcome (death).

EFFECT: method enables predicting the outcome of viral pneumonia in COVID-19 within 7–67 days of hospitalization.

1 cl, 2 tbl, 3 ex